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Visible pigmentation of the skin, hair,
and eyes depends primarily on the
presence of melanin(s) in those tissues.
Melanins are produced by specific cells
called melanocytes. Not only is the
type of melanin produced important,
but also its eventual distribution in the
tissue dramatically affects visible color,
which ultimately determines the func-
tions of the pigment, such as photo-
protection (Gilchrest, 2011). Clearly,
the specification, migration, and differ-
entiation during development of mela-
nocyte precursors (‘‘melanoblasts’’) in
specific patterns are essential for even-
tual pigmentation in adults (Kawakami
and Fisher, 2011). Following is a
synopsis of critical findings that have
led to our current understanding of
the biochemical pathways and mela-
nogenic factors involved in melanin
synthesis.
The key enzyme involved in the
synthesis of all types of melanins
from the initial precursor tyrosine is
tyrosinase (EC 1.14.18.1). Tyrosinases
have been described in many species,
including mammals and lower animals,
plants, and even fungi; in fact, the
earliest observations of the catalytic
function of tyrosinase were made in
extracts of mushrooms (Bourquelot
and Bertrand, 1895), which are still
widely used today as a highly enriched
source of that enzyme. All tyrosinases
depend on the binding of copper for
their catalytic function (Lerner et al.,
1950; Lerch et al., 1986), although
their substrate specificities and physical
properties can differ dramatically de-
pending on the species (Lerner et al.,
1951; Hearing et al., 1980). The rate-
limiting initial step in the biosynthesis
of melanin was initially thought to be
the hydroxylation of tyrosine to L-3,4-
dihydroxyphenylalanine (DOPA) and
its immediate subsequent oxidation
to DOPAquinone (DQ). In melano-
cytic cells, the DQ formed will be
spontaneously converted to an orange-
colored intermediate known as DOPA-
chrome. In vitro, the DOPAchrome
will spontaneously lose its carboxylic
acid group to form 5,6-dihydroxyindole
(DHI), which can then further oxidize
and polymerize to form a dense, high-
molecular-weight complex now known
as DHI-melanin. This was initially
reported by Raper (1926), and the
pathway was later refined by Mason
(1948); hence, the biosynthetic path-
way is frequently referred to as the
Raper–Mason pathway. Throughout
the 1950s, 1960s, and 1970s, the col-
laborative research groups at Yale
(headed by AB Lerner) and Harvard
(headed by TB Fitzpatrick) played key
roles in defining the involvement of
tyrosinase in the human skin pigmenta-
tion (Fitzpatrick et al., 1950), how its
activities were confined to melano-
somes and how those organelles devel-
oped (Seiji et al., 1961; Szabo et al.,
1969), and the disruptions that oc-
curred in those processes in many skin
pigmentary diseases (Breathnach et al.,
1965; Kawamura et al., 1971; Lerner
and Nordlund, 1978; Rees, 2011;
Spritz, 2011). Those findings, plus the
training of many post-doctoral fellows
and clinicians in their groups, played a
major role in establishing research
centers in Asia, Europe, and the Amer-
icas, which still have a strong influence
on studies of skin pigmentation and
related pigmentary diseases. As sum-
marized in Figure 1, recent revisions of
this melanogenic pathway have shown
that DOPA is not a distinct intermedi-
ate produced initially from tyrosine, but
is in fact produced later in the pathway
owing to the paired reduction of DQ
(Riley, 1999), and that downstream
tyrosinase-related enzymes can rear-
range the DOPAchrome to form a
carboxylated intermediate (DHI-2-car-
boxylic acid) known as DHICA, as
discussed below.
Analysis of the structures of the
high-molecular-weight polymers of
melanins depended on the develop-
ment of new techniques to analyze
these intractable pigments, and gradual
progress was made in defining those
structures, initially by Nicolaus’s group
in Naples and Swan’s group in the
United Kingdom (Swan, 1963; Nico-
laus et al., 1964). In working with
melanins found in nature, it quickly
became apparent that there were two
major types, the brown–black melanins
now collectively known as eumelanins,
and the yellow–red melanins now
collectively known as pheomelanins.
Prota’s group in Naples took the lead in
defining the structure of pheomelanin
and the involvement of sulfur as
responsible for its unique color and
properties (Prota, 1980). Prota and
colleagues, as well as Ito and Waka-
matsu in Japan (Ito et al., 1984),
developed a series of more sensitive
and specific assays for eumelanin and
pheomelanin intermediates that gradu-
ally formed the basis for our under-
standing of how they are formed in
melanocytes and how they are co-
polymerized in situ. The critical
role of sulfhydryl groups in reacting
immediately with DQ upon its forma-
tion to form various combinations
of cysteinylDOPAs and downstream
reactions of those intermediates, via
cysteinylDOPA-quinones and ben-
zothiazine intermediates, to produce
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pheomelanins were gradually defined
by the groups of Rorsman in Sweden,
Ito in Japan, Thody in the United
Kingdom, and Prota in Italy (Agrup
et al., 1979; Ito and Fujita, 1985; Thody
et al., 1991; Napolitano et al., 1994).
Studies characterizing the structural
and physical properties of melanins in
various tissues have also been led by
the groups of Simon in the United
States, d’Ischia and Zecca in Italy, and
Sarna in Poland (Sarna, 1992; Zecca
et al., 2001; Liu et al., 2005; Pezzella
et al., 2009). The determination to
produce eumelanin and/or pheomela-
nin is regulated physiologically, pri-
marily by the melanocortin 1 receptor
(MC1R) as modulated by its opposing
ligands, melanocyte stimulating hor-
mone (MSH) and agouti signaling
protein (ASIP); this is discussed in more
detail by Rees (2011).
Unexpectedly, in 1980, Pawelek
and colleagues reported the novel
finding that a biological factor pro-
duced in melanocytes was able to
prevent the spontaneous decarboxyla-
tion of DOPAchrome to DHI, which
led to the production of a more soluble
and lighter-colored carboxylated mela-
nin, now known as DHICA-melanin
(Ko¨rner and Pawelek, 1980). There was
some initial controversy about this
point, since that activity could be
mimicked in vitro by various divalent
metal cations (Palumbo et al., 1987),
but with the advent of molecular
biology and cloning, the race to
clone the tyrosinase gene led indirectly
to the identification of two tyrosi-
nase-related proteins (now known as
TYRP1 and DCT); one of those was
quickly shown to have the enzymatic
activity of DOPAchrome tautomerase
(Tsukamoto et al., 1992). Orlow and
colleagues then demonstrated that
the three tyrosinase-related melano-
genic enzymes polymerized in a com-
plex within melanocytes that facilitated
their physiological interactions (Orlow
et al., 1994).
Because of its critical role in pig-
mentation, and the disruptions in nor-
mal pigmentation expected to arise
from mutations in its encoding gene,
Kwon and colleagues initially cloned
the gene encoding tyrosinase (Kwon
et al., 1987) as well as another key
melanosomal protein now known to be
critically involved in melanosome struc-
ture, Pmel17 (Berson et al., 2001). As
noted above, cloning of the tyrosinase
gene led to the cloning of two other
closely related genes, and a number of
groups were instrumental in identify-
ing human pigmentary diseases asso-
ciated with each of those genes, most
notably by the laboratories of King and
Spritz in the United States (Getting and
King, 1994; Spritz, 1994) and later by
many other groups (reviewed in Hear-
ing and Leong, 2005; Nordlund et al.,
2006). Interestingly, the four known
forms of oculocutaneous albinism result
from molecular lesions that disrupt the
function of tyrosinase: OCA1, the most
severe form, results from mutations in
the gene encoding tyrosinase itself,
but OCA2, OCA3, and OCA4 (slightly
milder forms) result from mutations
in genes that affect the processing
and trafficking of tyrosinase to melano-
somes (P, TYRP1, and MATP, respec-
tively) (Toyofuku et al., 2001; Costin
et al., 2003). Many other pigmentary
disorders affect other basic processes
in addition to their effects on melano-
cytes and melanin production, most of
them by virtue of disrupting intracel-
lular trafficking pathways involved in
organelle biogenesis (including melano-
somes) and/or the intracellular transport
or transfer of melanosomes to neighbor-
ing keratinocytes. Such disorders in-
clude Hermansky–Pudlak syndrome,
Griscelli syndrome, and Chediak–Higa-
shi syndrome. Interested readers are
referred to an actively curated web site
that lists pigment-related genes and
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Figure 1. Scheme showing the melanogenic pathway that occurs within melanosome, leading to the production of eumelanin and/or pheomelanin.
Abbreviations used are as defined in the text. Adapted from Expert Review of Dermatology 2011;6:97–108, with permission from Expert Reviews
(Kondo and Hearing, 2011).
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associated diseases (http://www.espcr.
org/micemut/).
One final consideration that is now
becoming more widely accepted is the
synthesis and function of melanins in
less obscure tissues than the skin, hair,
and eyes. Melanocytes do occur, usu-
ally as minor populations, in a wide
variety of other tissues, and their
functions are currently a matter of
conjecture and study. Among those
other tissues are the inner ear, the
substantia nigra, the heart, and adipose
tissue. Evidence is accumulating that
the melanins play important protective
roles in those tissues (Brito and Kos,
2008; Zecca et al., 2008; Randhawa
et al., 2009). A recent article sum-
marizes many of those studies and
provides hints of interesting directions
they might take in the future (Brenner
and Hearing, 2009).
Melanins play important roles in
human skin for cosmetic appearance,
detoxification, and photoprotection,
among other functions. In lower spe-
cies, melanins play critical roles in
survival (e.g., in camouflage of prey
and predator, in thermal regulation in
amphibians, etc.) In humans, melanin
content (and thus visible pigmentation
of the skin) has a dramatic effect on
skin’s resistance to UV radiation da-
mage, and the risk of skin cancers in
lighter skin is 30- to 40-fold higher than
in darker skin. The roles of melanins in
other tissues are still being studied and
will no doubt provide a wealth of
information about their various func-
tions in the skin as well.
CONFLICT OF INTEREST
The author states no conflict of interest.
ACKNOWLEDGMENTS
This research was supported in part by the
Intramural Research Program of the NIH, National
Cancer Institute.
TO CITE THIS ARTICLE
Hearing VJ (2011) Determination of melanin
synthetic pathways. J Invest Dermatol 131:
E8–E11
REFERENCES
Agrup G, Hansson C, Rorsman H et al. (1979)
Intracellular distribution of DOPA and 5-S-cystei-
nylDOPA in pigment cells with minimal pigment
formation. Acta Dermatol Venereol Suppl
59:355–6
Berson JF, Harper DC, Tenza D et al. (2001)
Pmel17 initiates premelanosome morphogenesis
within multivesicular bodies. Mol Biol Cell
12:3451–64
Bourquelot E, Bertrand A (1895) Le bleuisse-
ment et le noircissement des champignons.
Comp Rend Soc Biol 2:582–4
Breathnach AS, Fitzpatrick TB, Wyllie LMA
(1965) Electron microscopy of melanocytes in
human piebaldism. J Invest Dermatol 45:28–37
Brenner M, Hearing VJ (2009) What are melano-
cytes really doing all day long y? Exp Dermatol
18:799–819
Brito FC, Kos L (2008) Timeline and distribution
of melanocyte precursors in the mouse heart.
Pigment Cell Melanoma Res 21:464–70
Costin GE, Valencia JC, Vieira WD et al. (2003)
Tyrosinase processing and intracellular trafficking
is disrupted in mouse primary melanocytes carry-
ing the uw mutation: a model for oculocutaneous
albinism (OCA) type 4. J Cell Sci 116:3203–12
Fitzpatrick TB, Becker Jr SW, Lerner AB et al.
(1950) Tyrosinase in human skin: demonstration
of its presence and of its role in human melanin
formation. Science 112:223–5
Getting WS, King RA (1994) Molecular basis of
oculocutaneous albinism. J Invest Dermatol
103:131S–6S
Gilchrest BA (2011) Molecular aspects of tann-
ing. J Invest Dermatol 131:E14–7
Hearing VJ, Ekel TM, Montague PM et al. (1980)
Mammalian tyrosinase. Stoichiometry and mea-
surement of reaction products. Biochim Biophys
Acta 611:251–68
Hearing VJ, Leong SPL (2005) From Melanocyte
to Melanoma: The Progression to Malignancy. 1st
ed. New York: Humana Press
Ito S, Fujita K (1985) Microanalysis of eumelanin
and pheomelanin in hair and melanomas by
chemical degradation and liquid chromatography.
Anal Biochem 144:527–36
Ito S, Fujita K, Takahashi H et al. (1984)
Characterization of melanogenesis in mouse and
guinea pig hair by chemical analysis of melanins
and of free and bound DOPA and 5-S-cysteinyl-
DOPA. J Invest Dermatol 83:12–4
Kawakami A, Fisher DE (2011) Key discoveries
in melanocyte development. J Invest Dermatol
131:E2–4
Kawamura K, Fitzpatrick TB, Seiji M (1971)
Biology of Normal and Abnormal Melanocytes.
Baltimore: University Park Press
Kondo T, Hearing VJ (2011) Update on the
regulation of melanocyte function and skin
pigmentation. Expert Rev Dermatol 6:97–108
Ko¨rner AM, Pawelek JM (1980) DOPAchrome
conversion: a possible control point in melanin
biosynthesis. J Invest Dermatol 75:192–5
Kwon BS, Haq AK, Pomerantz SH et al. (1987)
Isolation and sequence of a cDNA locus for human
tyrosinase that maps at the mouse c-albino locus.
Proc Natl Acad Sci USA 84:7473–7
Lerch K, Huber M, Scheider HJ et al. (1986)
Different origins of metal binding sites in bi-
nuclear copper proteins, tyrosinase and hemo-
cyanin. J Inorg Chem 26:213–7
Lerner AB, Fitzpatrick TB, Calkins E et al. (1950)
Mammalian tyrosinase; the relationship of
copper to enzymatic activity. J Biol Chem 187:
793–802
Lerner AB, Fitzpatrick TB, Calkins E et al. (1951)
Mammalian tyrosinase; action on substances
structurally related to tyrosine. J Biol Chem
191:799–806
Lerner AB, Nordlund JJ (1978) Vitiligo what is it?
Is it important? J Am Med Assoc 239:1183–7
Liu Y, Hong L, Wakamatsu K et al. (2005)
Comparison of structural and chemical properties
of black and red human hair melanosomes.
Photochem Photobiol 81:135–44
Mason HS (1948) The chemistry of melanin:
mechanism of the oxidation of dihydroxypheny-
lalanine by tyrosinase. J Biol Chem 172:83–99
Napolitano A, Costantini C, Crescenzi O et al.
(1994) Characterization of 1,4-benzothiazine
intermediates in the oxidative conversion of 5-
S-cysteinyldopa to pheomelanins. Tetrahedron
Lett 35:6365–8
Nicolaus RA, Piattelli M, Fattorusso E (1964)
The structure of melanins and melanogenesis. IV.
On some natural melanins. Tetrahedron 20:
1163–72
Nordlund JJ, Boissy RE, Hearing VJ et al.
(2006) The Pigmentary System: Physiology and
Pathophysiology. 2nd ed. Edinburgh: Blackwell
Science
Orlow SJ, Zhou BK, Chakraborty AK et al. (1994)
High-molecular-weight forms of tyrosinase and
the tyrosinase-related proteins: evidence for a
melanogenic complex. J Invest Dermatol 103:
196–201
Palumbo A, d’Ischia M, Misuraca G et al.
(1987) Effect of metal ions on the rearrangement
of DOPAchrome. Biochim Biophys Acta 925:
203–9
Pezzella A, Iadonisi A, Valerio S et al. (2009)
Disentangling eumelanin ‘‘black chromophore’’:
visible absorption changes as signatures of
oxidation state- and aggregation-dependent dy-
namic interactions in a model water-soluble 5,6-
dihydroxyindole polymer. J Am Chem Soc 131:
15270–5
Prota G (1980) Recent advances in the chemistry
of melanogenesis in mammals. J Invest Dermatol
75:122–7
Randhawa M, Huff T, Valencia JC et al. (2009)
Evidence for the ectopic synthesis of melanin in
human adipose tissue. FASEB J 23:835–43
Raper HS (1926) The tyrosinase-tyrosine reac-
tion: production of L-3.4-dihydroxyphenylalanine
from tyrosine. Biochem J 20:735–42
Rees JL (2011) The genetics of human pigmen-
tary disorders. J Invest Dermatol 131:E12–3
Riley PA (1999) The great DOPA mystery: the
source and significance of DOPA in phase I
melanogenesis. Cell Mol Biol (Noisy-le-grand)
45:951–60
Sarna T (1992) Properties and function of the
ocular melanin—a photobiophysical view. J
Photochem Photobiol 12:215–58
Seiji M, Fitzpatrick TB, Birbeck MSC (1961) The
melanosome: a distinctive subcellular particle of
mammalian melanocytes and the site of melano-
genesis. J Invest Dermatol 36:243–52
E10 NOVEMBER 2011 MILESTONES | CUTANEOUS BIOLOGY
Spritz RA (1994) Molecular genetics of
oculocutaneous albinism. Hum Mol Gen 3:
1469–75
Spritz RA (2011) The genetics of vitiligo. J Invest
Dermatol 131:E18–20
Swan GA (1963) Chemical structure of melanins.
Ann NY Acad Sci 100:1005–19
Szabo G, Gerald AB, Pathak MA et al.
(1969) Racial differences in the fate of
melanosomes in human epidermis. Nature
222:1081
Thody AJ, Higgins EM, Wakamatsu K et al. (1991)
Pheomelanin as well as eumelanin is present in
human epidermis. J Invest Dermatol 97:340–4
Toyofuku K, Wada I, Valencia JC et al. (2001)
Oculocutaneous albinism (OCA) types 1 and 3 are
ER retention diseases: mutations in tyrosinase
and/or Tyrp1 influence the maturation, degrada-
tion of calnexin association of the other. FASEB J
15:2149–61
Tsukamoto K, Jackson IJ, Urabe K et al. (1992)
A second tyrosinase-related protein, TRP2, is a
melanogenic enzyme termed DOPAchrome tauto-
merase. EMBO J 11:519–26
Zecca L, Bellei C, Costi P et al. (2008) New
melanic pigments in the human brain that
accumulate in aging and block environmental
toxic metals. Proc Natl Acad Sci USA 105:
17567–72
Zecca L, Tampellini D, Gerlach M et al. (2001)
Substantia nigra neuromelanin: structure, synth-
esis, and molecular behaviour. J Clin Pathol Mol
Pathol 54:414–8
MILESTONES | CUTANEOUS BIOLOGY NOVEMBER 2011 E11
